Bragar Eagel & Squire, P.C. is Investigating Eyenovia, Inc. (EYEN) on Behalf of Stockholders and Encourages Investors to Contact the Firm

New York, New York, UNITED STATES

NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Eyenovia, Inc. (NASDAQ: EYEN).  Our investigation concerns whether Eyenovia has violated the federal securities laws and/or engaged in other unlawful business practices.

The investigation concerns whether Eyenovia issued false and/or misleading statements and/or failed to disclose material adverse information in its filings with the U.S. Securities and Exchange Commission made in connection with its January 2018 initial public offering.  Eyenovia stock has declined over 45% from its IPO price of $10.

If you purchased or otherwise acquired Eyenovia shares pursuant and traceable to the IPO and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information concerning our investigation into Eyenovia, Inc. (please go to  For additional information about Bragar Eagel & Squire, P.C., please go to

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648